Registration - Amendment

INTERNATIONAL MYELOMA FOUNDATION for INTERNATIONAL MYELOMA FOUNDATION

Firm
Client
Income
—
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Veterans VET

Cancer Drug Coverage DoD Appropriations - CDMRP NIH Funding

LobbyistCovered position, as disclosed
DANIELLE DOHENY New —
ROBIN R LEVY New —
ANNA KELLEY SIDOROWICZ New —
RAYMOND LEE WEZIK New —

Budget/Appropriations BUD

Cancer Drug Coverage DoD Appropriations - CDMRP NIH Funding

LobbyistCovered position, as disclosed
DANIELLE DOHENY New —
ROBIN R LEVY New —
ANNA KELLEY SIDOROWICZ New —
RAYMOND LEE WEZIK New —

Health Issues HCR

Cancer Drug Coverage DoD Appropriations - CDMRP NIH Funding

LobbyistCovered position, as disclosed
DANIELLE DOHENY New —
ROBIN R LEVY New —
ANNA KELLEY SIDOROWICZ New —
RAYMOND LEE WEZIK New —

Medical/Disease Research/Clinical Labs MED

Cancer Drug Coverage DoD Appropriations - CDMRP NIH Funding

LobbyistCovered position, as disclosed
DANIELLE DOHENY New —
ROBIN R LEVY New —
ANNA KELLEY SIDOROWICZ New —
RAYMOND LEE WEZIK New —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.